A strain of Staphylococcus aureus resistant to ethidium bromide is described. The genetic determinants for the resistance are present on the same plasmid as the penicillinase genes.
.
Growth of certain strains of Staphylococcus aureus in the presence of ethidium bromide increases the rate of loss of their penicillinase plasmids (1 in 200 ,ug of ethidium bromide/ml but not in 240 ,ug/ml, whereas 1044N grew in 12 ,Ag/ml but not in 14 ,ug/ml. Phage 53, propagated in lytic cycle on 1044, was used to transduce ethidium bromide resistance back into 1044N (5). After 2 hr of growth at 37 C in casein hydrolysate medium, to allow phentotypic expression, transductants were selected on casein-hydrolysate agar containing 80 ,ug of ethidium bromide per ml, a concentration at which 1044 will grow but 1044N will not. All 52 ethidium bromide-resistant transductants tested had also acquired the ability to produce penicillinase as determined by a plate test (2) .
In experiments in which uptake of ethidium bromide was measured, we found that strain 1044N was capable of removing the drug from the medium, but strain 1044 was not (Table 1) . Thus, resistance to ethidium bromide may be due to this difference between the parent strain and the derived penicillinase-negative variant in the capacity to take up the drug.
Strain 1044 grows at a twofold higher concentration of proflavine in TSB than does 1044N. Ericson (3) has recently reported a strain of S. aureus resistant to a related acridine, acriflavine, in which the genetic determinants responsible for this resistance are carried on a penicillinase plasmid. We have not determined whether the gene determining the limited resistance to proflavine of strain 1044 is the same as that for ethidium bromide resistance, but the two resistances are present on the same penicillinase plasmid.
